at the American femara men of Reproductive Medicine 2005 Conference suggests that it may increase the risk of birth defects compared with a control group, femara men a more detailed follow-up study found no basis for concern when letrozole is preferred by athletes and bodybuilders for use during for.

Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006 Apr 28. PMID 16650422^ Endometriosis ESHRE abstract LetrozoleFrom Wikipedia, the femara men encyclopedia(Redirected from Femara)Jump femara men navigation, searchLetrozoleSystematic femara men name4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrileIdentifiersCAS number 112809-51-5ATC code L02BG04PubChem 3902DrugBank APRD01066Chemical dataFormula C17H11N5Mol. mass 285.303 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability 99.9%Protein femara men 60%, mainly to albuminMetabolism ?Half life 2 daysExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been used to treat endometriosis.[2][edit] References^ femara men T, Martin J, Al-Fadhli R, femara men N, Forman R, Hitkari J, Librach C, Greenblatt Librach.

(INN, trade name Femara®) is an oral non-steroidal aromatase femara men that has been used for ovulation induction for.